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Bacillus subtilis ATCC 6633 was grown in BHIB medium supplemented with Mn
2+
 for 96 h at 37
o
C in
a shaker incubator. After removing the microbial biomass, a lipopeptide biosurfactant was extracted
from the supernatant. Its structure was established by chemical and spectroscopy methods. The struc-
ture was confirmed by physical properties, such as Hydrophile-Lipophile Balance (HLB), surface activ-
ity and erythrocyte hemolytic capacity. The critical micelle concentration (cmc) and erythrocyte
hemolytic capacity of the biosurfactant were compared to those of surfactants such as SDS, BC (ben-
zalkonium chloride), TTAB (tetradecyltrimethylammonium bromide) and HTAB (hexadecyltrimeth-
ylammonium bromide). The maximum hemolytic effect for all surfactants mentioned was observed at
concentrations above cmc. The maximum hemolytic effect of synthetic surfactants was more than that
of the biosurfactant produced by B. subtilis ATCC 6633. Therefore, biosurfactant would be considered
a suitable surface-active agent due to low toxicity to the membrane. 
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In the past few decades, biosurfactants (surfactants of
microbial origin) have gained attention because of their
biodegradability, low toxicity, ecological acceptability, and
capacity to be manufactured from renewable and cheaper
substrates (Desai and Banat, 1997; Ishigami, 1997;
Makkar and Cameotra, 1999). Several structurally diverse
surface-active molecules are producible by a wide spec-
trum of microorganisms (bacteria, fungi, and yeasts).
There are six major types of biosurfactants: hydroxylated
and cross linked fatty acids (mycolic acids), glycolipids,
lipopolysaccharides, lipoproteins-lipopeptides, phospholip-
ids, and the complete cell itself (Desai and Banat, 1997).
Biosurfactants have been tested in environmental applica-
tions, such as bioremediation and dispersion of oil spills,
enhanced oil recovery, and transfer of crude oil, and have
been considered for surfactants of the future, especially in
the food, cosmetic, and in agricultural chemicals (Banat et
al., 2000). Bacillus subtilis produces a lipopeptide, called
surfactin, with exceptional surface activity (Heerklotz  et
al., 2001, Peypoux  et al., 1999). The compound has been
characterized as a cyclic lipopeptide containing a carbox-
ylic acid (3-hydroxy-13-methyl tetradecanoic acid) and
seven amino acids. Structural characteristics show the
presence of a heptapeptide with an LLDLLDL chiral
sequence linked to a β-hydroxy fatty acid, via a lactone
bond, (Peypoux  et al., 1999). Investigations of its other
physiological or biochemical actions have shown that it is
also an antibacterial, antitumoral compound against
Ehrilich ascites carcinoma cells, and a hypocholester-
olemic agent that inhibits cAMP phosphodiesterase and
has anti-HIV properties (Peypoux  et al., 1999). It has
only been since 1980 that surfactin has drawn the atten-
tion of a number of researchers, as an attractive supple-
ment to chemical surfactants that have detrimental effects
on the environment. If economic problems were not such a
hindrance, the petroleum industry would certainly find new
uses in agriculture and in environmental applications for
this compound (Peypoux et al., 1999). Recently, diverse
new activities have been demonstrated, including emulsifi-
cation (Razafindralambo et al., 1998), foaming (Razafind-
ralambo et al., 1998), antiviral, and antimycoplasmic
activities (Nissen et al., 1997). On top of such properties,
surfactin can differentiate viral cells from Mycoplasma
cells; proposals have been made to employ surfactin in
ensuring the safety of pharmaceutical products (Nissen et
al., 1997). In this work, we isolated surfactin (SU) from
culture of B. subtilis ATCC 6633 and some of its prop-
erties were determined by using physicochemical meth-
ods. The critical micelle concentration and erythrocyte
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hemolytic capacity of the produced biosurfactant were
compared to those of synthetic surfactants, including
SDS, BC, TTAB, and HTAB. 
Materials and Methods
Test organism
B. subtilis ATCC 6633 was obtained from the Persian
Culture Type Collection, Theran, Iran. 
Cultivation of organism
Brain-Heart Infusion Broth (BHIB) medium supple-
mented with Mn
2+ 
at 1.3 × 10
-3
 M was used. B. subtilis
ATCC 6633 was grown in 500 ml Erlenmeyer flasks, each
containing 100 ml medium. The flasks were incubated at
37
o
C on a shaker incubator (ISH-3000, Akhtarian) at 220
rpm for 96 h (Randhir, 1997).
Isolation and purification of biosurfactant
After the bacterial cells were removed from the liquid cul-
ture by centrifuging at 15000 × g for 25 min at 10
o
C in a
Beckman centrifuge with the use of a mod. JA. 25.50
rotor, crude biosurfactant was isolated by adding 6 M HCl
to the supernatant. A flocculated precipitate formed at pH
2.0, and was collected by centrifuging (15000 × g for 20
min, 10
o
C). The precipitate was dried under vacuum in a
dessicator and kept overnight at 4
o
C. The crude product
was resuspended in dichloromethane and stirred over-
night. The suspension was then filtered through Whatman
No. 1 filter paper to remove any coarse impurities. The
filtrate was extracted twice with equal volumes of distilled
water (pH 8.0) after stirring for 20 min. After this period,
the mixture was transferred into a separating funnel and
left for 3 h to allow for the separation of the two phases.
The aqueous phases containing the biosurfactant were
withdrawn and acidified to pH 2.0 through the addition of
6 M HCl. The biosurfactant, which was precipitated in the
form of white to yellowish crystals, was recovered by
centrifuging at 15000 × g for 15 min, dried under vacuum,
and weighed to evaluate the yield (Cooper et al., 1981;
Feignier et al., 1995; Carrillo et al., 1996; Desai and
Banat 1997; Randhir, 1997).
Circular dicroism (CD) spectroscopy
CD spectrum was measured at 25
o
C using an AVIV
model 62A DS spectropolarimeter (AVIV, USA). The CD
spectroscopic measurement was carried out in a 1 mm
path-length cuvette (Provencher and Glochner, 1981).
Infrared analysis
Infrared (Perkin Elmer paragon 1000) spectroscopy was
used to confirm the exact structure of the biosurfactant
obtained from the B. subtilis ATCC 6633. IR spectra were
collected between 400 and 4000 wave numbers (cm
-1
)
(Cooper et al., 1981).
UV spectroscopy
The sample was dissolved in dichloromethane and UV spec-
tra were obtained between 200 to 450 nm, using a UV-Vis-
ible Spectrophotometer (UV-160A, Shimadzu Corporation,
Japan) (Arima et al., 1968). 
Identification of fatty acid
The biosurfactant was hydrolyzed with 6 M HCl at 110
o
C
for 20 h and the lipid moiety was subsequently separated
by extraction with chloroform. Several drops of bromine
water were then added to the extract (Feignier et al., 1995;
Peypoux et al., 1994).
Identification of amino acids
Ninhydrin and biuret reactions were used in order to
identify the amino acids. The ninhydrin reagent was
added to the sample. A deep blue color developed after
the heating of amino acid or peptide with ninhydrin. The
biuret reagent was then added to the sample. A positive
result was then indicated by a violet or pink ring, due to
the reaction of peptide bond proteins or short-chain
polypeptides, respectively. Such a result would not occur
in the presence of free amino acids (Feignier et al.,
1995).
Determination of Hydrophile-Lipophile Balance (HLB)
Two emulsifiers (an oil-soluble, Span 80, and a water-
soluble, Tween 80) were first selected; one with a low
HLB value, emulsion A, and the other with a high HLB
value, emulsion B, (each containing 0.5% of surfactant).
A series of emulsions were prepared which covered both
stock emulsions, A and B, by mixing them in varying
proportions. Therefore, an emulsion (water, oil) was pre-
pared with mixture of biosurfactant and the other surfac-
tant with known HLB, which was added to the graduated
tube. The tubes were centrifuged at 1500 rpm. The
amount of aqueous phase separated was measured in mil-
liliters using the graduations on the tubes at two minute
intervals. Four readings were taken for each emulsion
and compared with other emulsions in the series. The net
HLB value of the biosurfactant emulsion was equal to the
HLB of emulsion with the same value of separation
phase. The HLB value of biosurfactant was then calcu-
lated from biosurfactant emulsion Required HLB (RHLB)
(Orafidiya et al., 2002). 
Red blood cell suspension
Approximately 10 ml of blood from a healthy volunteer
was taken and added to a heparinized tube and placed in
ice. The plasma and buffy coat were removed by centri-
fuging at 2200 g for 10 min. The erythrocytes were
washed three times, in at least five times their volume of
McIlvaine's buffer, at pH 7.0. The erythrocytes were
adjusted to approximately 12% hematocrit by resuspend-
ing them in buffer to 3.33 times their original weight. The
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erythrocyte suspension was stored on ice at 4
o
C and was
used within 48 h of collection (Gould et al., 2000).
Erythrocyte hemolytic measurement
A suspension of red blood cells (0.2 ml) was then incu-
bated for the required time with an equal volume of the
test sample, prepared in McIlvaine’s buffer, at 37
o
C. To
assay for the amount of haemoglobin released after incu-
bation, the mixtures were spun in a microcentrifuge
(Biofuge Pico, Germany) for 15 sec, and 0.2 ml of the
resulting supernatant was added to 3 ml Drabkin’s reagent.
Positive controls consisted of 0.2 ml samples, taken from
uncentrifuged mixtures of erythrocyte suspensions (0.2 ml)
and buffer (0.2 ml), which were added to 3 ml Drabkin’s
reagent to obtain a value for 100% haemolysis. A negative
control, included to assess the levels of spontaneous
hemolytic, comprised 0.2 ml buffer mixed with 0.2 ml
erythrocytes. After centrifugation for 15 sec, 0.2 ml sample
of supernatant was added to 3 ml Drabkin’s reagent. The
absorbance (540 nm) of the samples was determined spec-
trophotometrically and the values were expressed as a per-
centage of the maximum hemolysis (Gould et al., 2000).
Critical micelle concentration determination
Different aqueous concentrations of surfactants were pre-
pared. Surface tensions were measured with a tensiometer
using the duNouy procedure (model-703, Sigma) with a
platinum ring at 23
o
C. The surface tension-concentration
plots were used to determine critical micelle concentra-
tions (cmc) (Randhir, 1997). 
Results and Discussion
Characterization of biosurfactant
The FTIR spectrum of the sample (Fig. 1); showed strong







. These bands resulted from the stretching mode
of N-H, stretching mode of the C=O bond, and the defor-
mation mode (combined C-N stretching mode) of the N-













sample. The absorption region at 1740 - 1680 cm
-1
 was
due to lactone carbonyl absorption, a result which is com-
parable with another report (Ferre et al, 1997). A far UV
CD spectrum of biosurfactant showed the behavior of β-
sheet form in phosphate buffer solution (Fig. 2). The ease
of micelle formation may reflect the ease of the piling of
biosurfactant molecules organized by β-sheet formation.
The exposure of a large number of carboxylic groups on
the surface due to β-sheet organization may contribute to
the special behaviors of biosurfactant such as the ease of
surface β-sheet micelles and the ease of surface adsorp-
tion (Ishigami et al., 1994). On the other hand, presence
of peptide bonds was clearly demonstrable from UV spec-
trum at a range of 237 nm, which indicated the product
was lipopeptide, as previously has confirmed by Arima et
al. These results indicate that the product contains ali-
phatic hydrocarbons as well as a peptide-like moiety. Bro-
mine water reaction was negative; indicating that the fatty
acid chain was saturated. Ninhydrin reaction was nega-
tive, indicating that the peptide has a blocked N-terminal.
Biuret reaction was positive indication for polypeptides, a
finding which is verified by other reports (Arima et al.,
1968; Cooper et al., 1981; Ferre et al., 1997 and Ishigami
et al., 1994). The results indicate that the biosurfactant has
a lipopeptide structure.
HLB property
The HLB of the biosurfactant was 21.27. According to
Griffin’s HLB scale (Kayes, 1989), it has high HLB and
therefore is an o/w emulsifier, detergent, and solubilizing
agent.
Fig. 1. IR spectrum of biosurfactant.
Fig. 2. Far UV CD spectrum of biosurfactant at 25
o
C.
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Surface activity and hemolytic capacity
According to the data obtained in this study, the average
surface tension of pure water at 23
o
C was 72.54 ± 0.74
mN/m, and SDS showed the maximum lowering surface
tension activity (Fig. 3). Fig. 4 shows the hemolytic
capacity of SDS, BC, TTAB, HTAB, and the produced
biosurfactant. The results indicate that among surfactants
tested, HTAB had the maximum efficacy for disruption of
red blood cell membranes. As Fig. 4, indicates, hemolytic
capacity of surfactants increases with concentration, and
the definite concentration of their hemolytic capacity
(~ 100%) was above the relevant critical micelle concen-
tration. The increase in membrane permeability and sub-
sequent osmotic lysis of the cell is thought to be due to the
formation of mixed micelles in the lipid bilayer
(Vinardell, 1996). According to the data presented in this
study, the hemolytic activity of chemical surfactants
(SDS, BC, TTAB, and HTAB) was more than that of the
biosurfactant produced by B. subtilis ATCC 6633. The
cationic surfactants (TTAB and HTAB) showed high
hemolytic efficacy compared to anionic surfactants (SDS
and biosurfactant). Similar to the case of synthetic sur-
factants, erythrocyte hemolytic measurement showed that
the product was able to rupture erythrocytes, and therefore
could be used as an absorption enhancer. Surface tension
study of the biosurfactant showed that cmc was above
minimal hemolytic concentration (MHC).
In conclusion the results indicate that the product has
lipopeptide structure. Biosurfactant produced by B. sub-
tilis ATCC 6633 with various activities, such as detergent,
solubilizing, and absorption enhancer properties, can be
used as an interesting compound in the pharmaceutical
industry, as well as energy-related and environmental
fields. Due to its low toxicity to the membranes, it would
be considered a suitable surfactant in drug formulations. 
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